Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-10-11
Clinical Trial Update: Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) [Phase 2]
Phase 2 trial update evaluating first-line combination therapy of sintilimab and anlotinib for advanced non-small cell lung cancer (NSCLC).
CLINICAL_TRIALS trial_result · 2019-10-09
Clinical Trial Update: A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study evaluating PLX3397 in combination with pembrolizumab in advanced melanoma and other solid tumors was terminated; results w…
CLINICAL_TRIALS trial_result · 2019-10-07
Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032) [Phase 1]
Phase 1 study in Chinese participants with non-small cell lung cancer evaluating safety, tolerability, pharmacokinetics, and efficacy of pem…
CLINICAL_TRIALS trial_result · 2019-10-03
Clinical Trial Update: Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paclitaxel, carboplatin, and PF-05212384 in advanced or metastatic non-small cell lung cancer has been…
CLINICAL_TRIALS trial_result · 2019-10-01
Clinical Trial Update: Afatinib in NSCLC With HER2 Mutation [Phase 2]
This update reports results from a Phase 2 trial of afatinib in non-small cell lung cancer patients with HER2 mutations. The study has compl…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2019-10-01
Clinical Trial Update: A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating sequential anlotinib followed by EP regimen with concurrent radiotherapy for unresectable stage III non-small cell …
CLINICAL_TRIALS trial_result · 2019-09-27
Clinical Trial Update: A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC [Phase 2]
Phase 2 trial investigating SHR-1210 with carboplatin and paclitaxel-albumin in resectable non-small cell lung cancer; status is currently u…
CLINICAL_TRIALS trial_result · 2019-09-26
Clinical Trial Update: SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating SBRT with sintilimab and GM-CSF for advanced non-small cell lung cancer (Stage IV).
CLINICAL_TRIALS trial_result · 2019-09-24
Clinical Trial Update: A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
A Phase 2 trial evaluating lurbinectedin alone or with gemcitabine versus docetaxel in second-line non-small cell lung cancer has completed …
CLINICAL_TRIALS trial_result · 2019-09-19
Clinical Trial Update: Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy [Phase 2]
Phase 2 trial update on refining adjuvant therapy for early-stage non-small cell lung cancer (completed).
CLINICAL_TRIALS trial_result · 2019-09-17
Clinical Trial Update: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer [Phase 2]
Phase 2 trial investigating lisinopril to reduce shortness of breath from radiation therapy in patients with lung cancer has completed with …
CLINICAL_TRIALS trial_result · 2019-09-13
Clinical Trial Update: Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)
Clinical trial update reporting safety and efficacy data for crizotinib under a regulatory post-marketing commitment plan for non-small cell…
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC [Phase 3]
A randomized Phase III trial comparing surgery alone to surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung c…
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab alone and in combination with acalabrutinib in advanced non-small cell lung cancer has completed with…
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer [Phase 3]
A Phase 3 trial comparing two doses of pemetrexed in non-small cell lung cancer has completed.
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial updating the combination of cetuximab with NK immunotherapy for recurrent non-small cell lung cancer (Phase 1/Phase 2) has co…
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of cryosurgery and NK cell immunotherapy for metastatic non-small cell lung cancer has completed.
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of γδ T cell therapy for non-small cell lung cancer without EGFR mutation.
CLINICAL_TRIALS trial_result · 2019-09-12
Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a high-activity natural killer immunotherapy for small metastases in non-small cell lung cancer.
CLINICAL_TRIALS trial_result · 2019-09-10
Clinical Trial Update: Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients [Phase 3]
Phase 3 trial update for an EGF cancer vaccine in stage IV biomarker-positive, wild-type EGFR non-small cell lung cancer; study terminated.
CLINICAL_TRIALS trial_result · 2019-09-10
Clinical Trial Update: Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET [Phase 2]
Phase 2 trial of MGCD265 in non-small cell lung cancer with activating MET alterations has completed with results posted.
CLINICAL_TRIALS trial_result · 2019-09-10
Clinical Trial Update: Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for etirinotecan pegol in refractory brain metastases, extensive-stage small cell lung cancer, recurrent NSCLC, metasta…
CLINICAL_TRIALS trial_result · 2019-09-10
Clinical Trial Update: Study of KN046 With Chemotherapy in First Line Advanced NSCLC [Phase 2]
Phase 2 clinical trial update for KN046 in combination with chemotherapy as first-line treatment for advanced non-small cell lung cancer.
CLINICAL_TRIALS trial_result · 2019-09-06
Clinical Trial Update: Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing erlotinib versus placebo after chemoradiotherapy in stage III non-small cell lung cancer completed with posted resul…
CLINICAL_TRIALS trial_result · 2019-08-28
Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin [Phase 3]
Phase 3 trial in squamous non-small cell lung cancer comparing ipilimumab with paclitaxel and carboplatin to placebo with paclitaxel and car…